Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Yoshi Itoh Dupuytren's award
Yoshi Itoh (r) receives the International Dupuytren award 2022 from Dominic Furniss (l)

Yoshi's paper: “A common SNP risk variant MT1-MMP causative for Dupuytren’s disease has a specific defect in collagenolytic activity”, published in Matrix Biology was recognised as the best paper published on the subject of Dupuytren's Disease in the previous year.

On receiving the award Yoshi said: “It is wonderful that our discovery was recognised by the International Dupuytren Society. I feel very honoured to receive the International Dupuytren's Award 2022. Our study demonstrated that one of the causes of Dupuytren disease is the impaired collagen catabolism caused by the single nucleotide polymorphism at the gene of the crucial cell surface collagenolytic enzyme, MT1-MMP/MMP-14. We hope that our discovery will lead to the development of novel therapeutics for Dupuytren disease in the future.

"Around 30% of the worldwide population or 35% of the European population have the low collagenolytic SNP allele. Therefore, further investigation on the impact of the SNP in different pathophysiological conditions is very important. Finally, I wish to express my appreciation to all the authors of the paper. Without everyones’ contributions, it would have been impossible to complete the paper.”

Professor Dominic Furniss, who presented Yoshi with the award said: “My congratulations go to Yoshi for this recognition of his research by the International Dupuytren Society. This is the sixth year running that a team from NDORMS has won the award, which demonstrates our world leading research in this area.”

The International Dupuytren Award recognises exceptional scientific publications on research or clinical treatment of Dupuytren and/or Ledderhose disease. 

Similar stories

Kennedy researchers contribute to UK-wide AI and bioscience training initiative

Together with a group of Oxford researchers, Mark Coles, Professor of Immunology at the Kennedy Institute, will co-lead the Enabling Next-generation AI for a Bioscience-Led Economy (ENAIBLE) initiative.

Researchers win prestigious Kennedy Trust grant awards

Two Kennedy researchers have been awarded highly competitive Kennedy Trust Transition Fellowships, supporting their journey towards independent research leadership, and another receiving a Research Ignition Award to kick-start innovative interdisciplinary research.

Linh Nguyen receives Lee Placito Research Fellowship

Congratulations to Linh Nguyen who has been awarded a Lee Placito Research Fellowship in Gastrointestinal Disease.

NDORMS researchers honoured in the Recognition of Distinction Scheme 2025

Jelena Bezbradica Mirkovic, Audrey Gerard, Karthik Ramasamy and Sarah Snelling have been awarded the title of ‘Full Professor’ in the University of Oxford’s 2025 Recognition of Distinction exercise.

Dr Mariana Borsa to start her own research group in Basel

Dr Mariana Borsa, Postdoctoral Researcher in autophagy and ageing, will leave the Kennedy Institute to start an exciting new chapter in Switzerland as a Principal Investigator.

NDORMS recognised as a European Centre of Excellence

NDORMS has been awarded the designation of a EULAR Centre of Excellence for a third consecutive term. This prestigious award is a recognition of the department’s contribution to advancing the science of rheumatic and musculoskeletal diseases.